Israeli firm announces success in cell-transplant treatment for ALS

Israeli bio-pharmaceutical company Kadimastem announced on Wednesday a successful trial for an ALS (Amyotrophic Lateral Sclerosis) treatment based on healthy cells tran

梁晨婕

梁晨婕

4 Years ago

Science trial trials wednesday were would